학술논문

An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension
Document Type
Article
Source
In: Pulmonary Circulation. (Pulmonary Circulation, January 2022, 12(1))
Subject
Language
English
ISSN
20458940
20458932